399 Pharmacokinetics and Pharmacodynamics of TAK-733, an Investigational, Oral MEK Inhibitor, in Patients with Advanced Nonhematologic Malignancies

Authors :: S. Faucette
E. Gangolli
Xiaofei Zhou
S. Kaun
Karthik Venkatakrishnan
V. Bozon
Source :: European Journal of Cancer. 48:121-122
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: Cancer Research
Oncology
Pharmacokinetics
business.industry
MEK inhibitor
Medicine
In patient
Pharmacology
business

Full Text Access

Tools